BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27055353)

  • 21. Managed care: a view from Europe.
    Erdmann Y; Wilson R
    Annu Rev Public Health; 2001; 22():273-91. PubMed ID: 11274522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Managed competition in the Netherlands: Do insurers have incentives to steer on quality?
    Stolper KCF; Boonen LHHM; Schut FT; Varkevisser M
    Health Policy; 2019 Mar; 123(3):293-299. PubMed ID: 30268584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical service provider networks.
    Mougeot M; Naegelen F
    Health Econ; 2018 Aug; 27(8):1201-1217. PubMed ID: 29774623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consumer choice among Mutual Healthcare Purchasers: a feasible option for China?
    Xu W; van de Ven WP
    Soc Sci Med; 2013 Nov; 96():277-84. PubMed ID: 23261255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Choice of insurer for basic health insurance restricted by supplementary insurance.
    Duijmelinck DM; van de Ven WP
    Eur J Health Econ; 2014 Sep; 15(7):737-46. PubMed ID: 23887827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addressing health care market reform through an insurance exchange: essential policy components, the public plan option, and other issues to consider.
    Fronstin P; Ross MN
    EBRI Issue Brief; 2009 Jun; (330):1-22. PubMed ID: 19545086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health insurance exchanges in Switzerland and the Netherlands offer five key lessons for the operations of US exchanges.
    van Ginneken E; Swartz K; Van der Wees P
    Health Aff (Millwood); 2013 Apr; 32(4):744-52. PubMed ID: 23569055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insurer-provider integration, credible commitment, and managed-care backlash.
    Miller NH
    J Health Econ; 2006 Sep; 25(5):861-76. PubMed ID: 16712987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. All together now.
    Kosterlitz J
    Natl J (Wash); 1993 Nov; 25(46):2704-8. PubMed ID: 10130066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The out-of-network benefit: problems and policy solutions.
    Kyanko KA; Busch SH
    Inquiry; 2012-2013 Winter; 49(4):352-61. PubMed ID: 23469678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current trends in the integration and reimbursement of complementary and alternative medicine by managed care organizations (MCOs) and insurance providers: 1998 update and cohort analysis.
    Pelletier KR; Astin JA; Haskell WL
    Am J Health Promot; 1999; 14(2):125-33. PubMed ID: 10724724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating the Impact of Health Insurance Industry Consolidation: Learning from Experience.
    Dafny LS
    Issue Brief (Commonw Fund); 2015 Nov; 33():1-11. PubMed ID: 26634241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Awakening consumer stewardship of health benefits: prevalence and differentiation of new health plan models.
    Rosenthal M; Milstein A
    Health Serv Res; 2004 Aug; 39(4 Pt 2):1055-70. PubMed ID: 15230911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Healthcare transition managers make market exits easier for insurers.
    Resnick LR
    Healthc Financ Manage; 1999 Oct; 53(10):39-41. PubMed ID: 11066665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Case for a Private Healthcare Insurance Monopoly.
    Orzechowski PE
    Appl Health Econ Health Policy; 2018 Aug; 16(4):433-443. PubMed ID: 29626323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Empowering the demand side: from regulation to purchasing.
    Kronick R
    Inquiry; 1992; 29(2):213-30. PubMed ID: 1612721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Switching gains and health plan price elasticities: 20 years of managed competition reforms in The Netherlands.
    Douven R; Katona K; T Schut F; Shestalova V
    Eur J Health Econ; 2017 Nov; 18(8):1047-1064. PubMed ID: 28243775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insurance product design and its effects: trade-offs along the managed care continuum.
    Kemper P; Tu HT; Reschovsky JD; Schaefer E
    Inquiry; 2002; 39(2):101-17. PubMed ID: 12371566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Managed competition in The Netherlands: lessons from five years of health care reform.
    van de Ven W; Rutten F
    Aust Health Rev; 1995; 18(1):9-27. PubMed ID: 10141966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients as consumers: courts, contracts, and the new medical marketplace.
    Hall MA; Schneider CE
    Mich Law Rev; 2008 Feb; 106(4):643-89. PubMed ID: 18354872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.